NASDAQ:IMTX Immatics - IMTX News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. $7.15 +0.41 (+6.08%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$6.60▼$7.2650-Day Range$6.74▼$8.8852-Week Range$5.75▼$13.60Volume784,410 shsAverage Volume228,705 shsMarket Capitalization$545.04 millionP/E Ratio9.66Dividend YieldN/APrice Target$22.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address IMTX Media Mentions By Week IMTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMTX News Sentiment▼0.710.67▲Average Medical News Sentiment IMTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMTX Articles This Week▼171▲IMTX Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImmatics (NASDAQ:IMTX) Receives New Coverage from Analysts at Bryan, Garnier & Comarketbeat.com - March 24 at 9:21 AMImmatics to Post Q1 2023 Earnings of ($0.42) Per Share, SVB Leerink Forecasts (NASDAQ:IMTX)marketbeat.com - March 23 at 6:58 AMImmatics (NASDAQ:IMTX) Research Coverage Started at Bryan, Garnier & Coamericanbankingnews.com - March 27 at 2:52 AMImmatics (NASDAQ:IMTX) Given New $25.00 Price Target at Chardan Capitalamericanbankingnews.com - March 26 at 4:24 AMImmatics (NASDAQ:IMTX) Forecasted to Earn Q1 2023 Earnings of ($0.42) Per Shareamericanbankingnews.com - March 25 at 1:52 AMImmatics Forecasted to Post FY2023 Earnings of ($1.71) Per Share (NASDAQ:IMTX)americanbankingnews.com - March 24 at 6:52 AMImmatics Announces Full Year 2022 Financial Results and Corporate Updatefinance.yahoo.com - March 21 at 7:54 AMImmatics (IMTX) Set to Announce Earnings on Tuesdayamericanbankingnews.com - March 20 at 9:00 AMImmatics (IMTX) Set to Announce Quarterly Earnings on Tuesdayamericanbankingnews.com - March 20 at 8:08 AMThe past three years for Immatics (NASDAQ:IMTX) investors has not been profitablefinance.yahoo.com - March 20 at 6:46 AMImmatics (NASDAQ:IMTX) Sees Significant Growth in Short Interestamericanbankingnews.com - March 17 at 9:34 AMAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Immatics (IMTX)markets.businessinsider.com - February 6 at 10:00 AMImmatics N.V.'s (NASDAQ:IMTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?finance.yahoo.com - December 17 at 10:09 AMIMTX.O - Immatics NV | Stock Price & Latest News | Reutersreuters.com - December 16 at 10:49 PMImmatics Announces Third Quarter 2022 Financial Results and Business Updatefinance.yahoo.com - November 17 at 10:44 AMImmatics (IMTX) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - November 17 at 10:44 AMDoes Immatics (IMTX) Have the Potential to Rally 77% as Wall Street Analysts Expect?finance.yahoo.com - October 31 at 12:30 PMWall Street Analysts See an 81% Upside in Immatics (IMTX): Can the Stock Really Move This High?msn.com - October 14 at 3:07 PMShareholders in Immatics (NASDAQ:IMTX) are in the red if they invested a year agonz.finance.yahoo.com - October 10 at 3:41 PMHot Stocks: Macau stocks drop on COVID worries; EDU, TAL plunge; AXNX downgrade; IMTX rises on clinical dataseekingalpha.com - October 10 at 3:41 PMImmatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancersmsn.com - October 10 at 10:41 AMImmatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAMEfinance.yahoo.com - October 10 at 10:41 AMImmatics Announces $110 Million Underwritten Offering of Ordinary Sharesfinance.yahoo.com - October 10 at 10:41 AMIMTX Immatics N.V.seekingalpha.com - September 27 at 8:15 PMFurther weakness as Immatics (NASDAQ:IMTX) drops 11% this week, taking one-year losses to 26%nasdaq.com - September 13 at 7:06 PMIMTX.OQ - Immatics NV | Stock Price & Latest News | Reutersreuters.com - August 29 at 6:05 PMImmatics Announces First Cancer Patient Treated with Second-Generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAMEfinanznachrichten.de - August 24 at 8:49 PMImmatics Announces First Cancer Patient Treated with Second-Generation ACTengine® TCR-T Candidate IMA203CD8 Targeting PRAMEfinance.yahoo.com - August 23 at 2:45 PMWall Street Analysts Think Immatics (IMTX) Could Surge 82%: Read This Before Placing a Betfinance.yahoo.com - August 12 at 12:59 PMImmatics Announces Second Quarter 2022 Financial Results and Business Updatenz.finance.yahoo.com - August 9 at 8:33 AMStrength Seen in Immatics (IMTX): Can Its 18% Jump Turn into More Strength?nasdaq.com - July 20 at 1:34 PMDo Its Financials Have Any Role To Play In Driving Immatics N.V.'s (NASDAQ:IMTX) Stock Up Recently?finance.yahoo.com - June 25 at 5:30 PMImmatics NV Ordinary Shares - Stock Chartmorningstar.com - June 17 at 10:53 PMEditas in licensing deal with Immatics for cancer therapiesseekingalpha.com - June 9 at 6:28 AMImmatics GAAP EPS of €1.35, revenue of €102.91Mseekingalpha.com - June 2 at 10:19 AMImmatics Announces First Quarter 2022 Financial Results and Business Updatefinance.yahoo.com - June 2 at 10:19 AMImmatics (IMTX) Lags Q1 Earnings and Revenue Estimatesfinance.yahoo.com - June 2 at 10:19 AMImmatics stock rises on cell therapy program collaboration with Bristol Myersseekingalpha.com - June 2 at 10:19 AMWhat Kind Of Shareholders Own Immatics N.V. (NASDAQ:IMTX)?finance.yahoo.com - May 26 at 9:48 AMImmatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumorsmorningstar.com - May 10 at 7:52 AMImmatics Initiates Phase 1 Clinical Trial of IMA401 in Advanced Solid Tumorsmarkets.businessinsider.com - May 10 at 7:52 AMImmatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumorsfinance.yahoo.com - May 10 at 7:52 AMImmatics (NASDAQ:IMTX) shareholders have endured a 37% loss from investing in the stock a year agofinance.yahoo.com - May 3 at 1:35 PMWall Street Analysts See a 178% Upside in Immatics (IMTX): Can the Stock Really Move This High?finance.yahoo.com - April 15 at 2:21 PMAnalysts Are Optimistic We'll See A Profit From Immatics N.V. (NASDAQ:IMTX)finance.yahoo.com - March 31 at 6:36 PMImmatics Announces Full Year 2021 Financial Results and Corporate Updatefinanznachrichten.de - March 25 at 12:05 AMImmatics Cash Position As Of Dec. 31 $164.3Mbenzinga.com - March 23 at 9:48 AMHere's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situationfinance.yahoo.com - February 14 at 3:35 PMNews Flash: Analysts Just Made A Captivating Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecastsnasdaq.com - December 16 at 6:10 AMNews Flash: Analysts Just Made A Substantial Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecastsfinance.yahoo.com - December 16 at 6:10 AMImmatics inks $920M licensing deal with Bristol Myers Squibbbizjournals.com - December 14 at 7:50 AMBristol Myers, Immatics to Collaborate on IMA401 >BMY IMTXmarketwatch.com - December 14 at 7:50 AM Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:IMTX) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.